Trial Profile
Efficacy of Octreotide in the Prevention of Postoperative Complications After Pancreaticodudenectomy in Patients With Soft Pancreas and Non-dilated Pancreatic Duct: A Prospective Randomized Trial"
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2017
Price :
$35
*
At a glance
- Drugs Octreotide (Primary)
- Indications Postoperative complications
- Focus Therapeutic Use
- 03 Apr 2017 Status changed from active, no longer recruiting to completed.
- 26 Jun 2015 New trial record